{"schema_version":"secwatch.filing_event.v1","accession":"0001671284-24-000004","form_type":"8-K","ticker":null,"cik":"0001671284","company_name":"NeueHealth, Inc.","filed_at":"2024-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.051730+00:00","generated_at":"2026-06-07T05:20:21.287169+00:00","sec_items":["1.01","1.02","2.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Bright Health sells California Medicare Advantage business to Molina for $500M; repays secured debt","bullets":["Sale of Brand New Day and Central Health Plan closed Jan 1, 2024 for $500M cash.","Concurrently repaid $274.6M secured credit facility; eliminated all secured debt.","Remaining proceeds to fund continuing NeueHealth business; expects 2024 Adjusted EBITDA profitability.","Credit agreement terminated after payoff and $24.1M cash collateral for letters of credit."],"urls":{"canonical":"https://secwatch.observer/filing/0001671284-24-000004","json":"https://secwatch.observer/filing/0001671284-24-000004.json","markdown":"https://secwatch.observer/filing/0001671284-24-000004.md","text":"https://secwatch.observer/filing/0001671284-24-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671284/000167128424000004/0001671284-24-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671284/000167128424000004/bhg-20240102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T05:20:21.287169+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7ec2daa19d0c1f291c19d97d238c42bea4768a1b","claim":"NeueHealth, Inc. completed a disposition involving Molina Healthcare, Inc. for $500.0 million in cash (closed 2024-01-01).","evidence_excerpt":"pursuant to which, among other things, BHCC agreed to sell to Molina all of its shares of capital stock in CHP and BND (together, the “ MA Business ”) for an aggregate purchase price of $500.0 million in cash, subject to certain purchase price adjustments (such sale, the “ Transaction ”), and, following the consummation of the Transaction, each of BND and CHP would be a wholly owned subsidiary of Molina. Effective as of January 1, 2024, the Transaction was consummated.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1671284/000167128424000004/0001671284-24-000004-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Molina Healthcare, Inc."},{"label":"Consideration","value":"$500.0 million in cash"},{"label":"Closing","value":"2024-01-01"}],"fact_type":"ma_transaction"},{"claim_id":"68293665c212c7e0e0d7948a9bf74dd2ae791ce6","claim":"NeueHealth, Inc. terminated Credit Agreement dated as of March 1, 2021 with JPMorgan Chase Bank, N.A. and the Lenders valued at Payoff of $274.6 million and cash collateral of $24.1 million (effective 2024-01-02).","evidence_excerpt":"On January 2, 2024, both the Payoff Condition and the L/C Condition were satisfied and, as a result, the Consent and the Termination occurred.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1671284/000167128424000004/0001671284-24-000004-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"JPMorgan Chase Bank, N.A. and the Lenders"},{"label":"Value","value":"Payoff of $274.6 million and cash collateral of $24.1 million"},{"label":"Effective","value":"2024-01-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}